Home / Pravastatin / Canada
CA ATC C10AA03 · updated 2 Nov 2026
Pravastatin shortage in Canada
Is there a Pravastatin shortage in Canada?
Yes. As of 2 Nov 2026, 12 Pravastatin products are reported short in Canada, the first since 11 Apr 2014. No return date has been given. Main reason: manufacturing problem.
Also short in Italy, Spain, Austria, Belgium, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | RIVA-PRAVASTATIN (30 & 100) | LABORATOIRE RIVA INC | 11 Apr 2014 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RIVA-PRAVASTATIN (30 & 100) | LABORATOIRE RIVA INC | 11 Apr 2014 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RIVA-PRAVASTATIN (30 & 100) | LABORATOIRE RIVA INC | 11 Apr 2014 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACT PRAVASTATIN (100) | ACTAVIS PHARMA COMPANY | 17 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACT PRAVASTATIN (100) | ACTAVIS PHARMA COMPANY | 17 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACH-PRAVASTATIN (100) | ACCORD HEALTHCARE INC | 28 Jun 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | ACH-PRAVASTATIN (100) | ACCORD HEALTHCARE INC | 6 Dec 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | ACH-PRAVASTATIN (100) | ACCORD HEALTHCARE INC | 6 Dec 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | TEVA-PRAVASTATIN (100) | TEVA CANADA LIMITED | 31 Jul 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-PRAVASTATIN (100) | TEVA CANADA LIMITED | 2 Sep 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-PRAVASTATIN (100) | TEVA CANADA LIMITED | 25 Nov 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PMS-PRAVASTATIN (100) | PHARMASCIENCE INC | 3 Sep 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.